Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT)

Allan M Jordan, Tariq H Khan, Hugh Malkin, Helen M I Osborn

Research output: Contribution to journalArticlepeer-review

Abstract

The suitability of 4-di(2-chloroethyl)aminoanilino-4-hydroxyphenethylaminomethanone 2 to act as a prodrug for melanocyte-directed enzyme prodrug therapy (MDEPT) is assessed. Thus its synthesis, ability to generate a cytotoxic agent upon exposure to tyrosinase, and stability within different sera are reported. A comparison is made to illustrate that the new urea prodrug 2 is a more suitable candidate for MDEPT than the corresponding carbamate prodrug 1.

Original languageEnglish
Pages (from-to)2625-33
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume10
Issue number8
Publication statusPublished - Aug 2002

Keywords

  • Animals
  • Blood
  • Carbamates
  • Cattle
  • Cell Death
  • Drug Delivery Systems
  • Drug Stability
  • Enzymes
  • Humans
  • Melanocytes
  • Monophenol Monooxygenase
  • Prodrugs
  • Urea

Fingerprint

Dive into the research topics of 'Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT)'. Together they form a unique fingerprint.

Cite this